logo-loader

Full interview: LexaGene teams up with Assurance Scientific to beta test its diagnostic in humans

Published: 14:01 08 Aug 2019 EDT

LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) CEO Dr Jack Regan notes that the firm is teaming up with Assurance Scientific Laboratories (ASL) to test its rapid pathogen detection technology on human urine samples. Dr Regan says ASL has the ability to bring LexaGene's diagnostic in-house, validate it, and begin using it for clinical diagnostic.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

7 hours, 15 minutes ago